BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ZT006 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ZT006\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07230132-205@assetmemo.bio
DTSTAMP:20261121T005300Z
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261213
SUMMARY:ZT006: Phase 2 readout est. (NCT07230132)
DESCRIPTION:ZT006\, phase 2\, Obesity.\nStudy: Efficacy and Safety of ZT006
  in Overweight and Obese Participants\nEstimated primary completion: 12 De
 cember 2026. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/zt006#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072301
 32
URL:https://assetmemo.bio/drug/zt006#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
